Researchers Use Plasmid Gene Editing to Personalize Solid Tumor T-Cell Therapy.
JAMA, 328(22): 2201-2202 PMID 36511936 DOI 10.1001/jama.2022.20034
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.